LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 78 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,407 | -52.9% | 196,875 | +2.0% | 0.00% | – |
| Q2 2023 | $614,039 | +18.3% | 193,094 | -12.2% | 0.00% | – |
| Q1 2023 | $519,016 | +170.4% | 219,922 | +297.6% | 0.00% | – |
| Q4 2022 | $191,943 | -78.4% | 55,315 | -54.4% | 0.00% | – |
| Q3 2022 | $889,000 | +298.7% | 121,229 | +173.9% | 0.00% | – |
| Q1 2022 | $223,000 | +39.4% | 44,255 | +114.9% | 0.00% | – |
| Q4 2021 | $160,000 | -66.2% | 20,598 | -35.7% | 0.00% | – |
| Q3 2021 | $474,000 | – | 32,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |